Controlled trial of effect of documented cardiovascular risk scores on prescribing
- 1 February 2003
- Vol. 326 (7383) , 251-252
- https://doi.org/10.1136/bmj.326.7383.251
Abstract
We recruited patients with type 2 diabetes who had no history of cardiovascular disease or renal disease. All patients were aged 35–75 years and attending a hospital outpatient clinic. We recruited 323 patients (167 men and 156 women) attending the clinic consecutively. Patients were seen by one of six doctors who were unaware of the ongoing project. We allocated patients alternately to the experimental and control groups (162 experimental, 161 control), and all doctors saw an equal number of experimental and control patients. The University of Dundee special study module subcommittee approved this project on behalf of Tayside Committee on Medical Research Ethics.Keywords
This publication has 6 references indexed in Scilit:
- Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countriesThe Lancet, 2001
- Updated New Zealand cardiovascular disease risk-benefit prediction guideBMJ, 2000
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998